达卡巴嗪对3种模型均有明显的治疗作用。
The significant therapeutic effects of DITC on the 3 animal models were shown.
服用vemurafenib72小时后,药物开始发挥作用。服用该药物六个月后84%的病患依然存活,服用达卡巴嗪的病患服药六个月后生存率为64%。
Patients on vemurafenib saw the drug work within 72 hours and 84% of the patients were still alive after six months, compared with 64% of patients getting dacarbazine.
服用vemurafenib72小时后,药物开始发挥作用。服用该药物六个月后84%的病患依然存活,服用达卡巴嗪的病患服药六个月后生存率为64%。
Patients on vemurafenib saw the drug work within 72 hours and 84% of the patients were still alive after six months, compared with 64% of patients getting dacarbazine.
应用推荐